UK Mice Model Market (2025-2030)
The UK Mice Model Market was valued at $86.2 Million in 2025 and projected to reach to $143.1 Million by 2030, representing a compound annual growth rate of 10.7%. The UK mice model market is positioned for sustained growth through 2030, driven by the nation's strong pharmaceutical and biotechnology sector, coupled with increased R&D spending and regulatory requirements for preclinical testing.
UK Mice Model Market Trends and Insights
- The UK's robust pharmaceutical and biotechnology research infrastructure drives demand for preclinical testing models, with the UK hosting leading academic institutions and contract research organizations that rely heavily on mice models for drug development and disease research.
- The UK's commitment to advancing life sciences and reducing animal testing through refined methodologies positions the market for sustained expansion through 2030. The UK mice model market benefits from strong regulatory support and investment in biomedical research.
- The UK's position as a global hub for pharmaceutical innovation, combined with increasing R&D spending by both public and private sectors, fuels demand for high-quality, genetically characterized mice models.
- Between 2025 and 2030, the UK market is expected to experience accelerated growth driven by advances in genetic engineering, personalized medicine initiatives, and the rising complexity of disease models required for modern drug discovery..
Key Market Statistics
- CAGR (2025-2030) 10.7% CAGR
- Market Size, 2025 ~USD 86.2 Million
- Forecast, 2030 ~USD 143.1 Million
- Country UK
UK Mice Model Market Overview
Market Valuation :
The UK mice model market is valued at £86.2 million in 2025, with strong growth trajectory driven by increased investment in pharmaceutical R&D and regulatory requirements for preclinical testing.
Research Infrastructure :
The UK hosts world-leading academic institutions and contract research organizations including the Francis Crick Institute, Wellcome Sanger Institute, and numerous CROs that depend on mice models for drug development and disease research.
Regulatory Compliance :
UK regulatory frameworks and post-Brexit alignment with international standards continue to drive demand for validated mice models in preclinical studies for pharmaceutical and biotech companies.
Growth Trajectory :
The market is projected to reach £143.1 million by 2030, representing a 10.7% CAGR, outpacing the global average of 10% and reflecting the UK's commitment to life sciences innovation.
UK Mice Model Market Dynamics
- Leading academic institutions and contract research organizations continue to expand their capabilities, creating robust demand for high-quality mice models.
- The UK's post-Brexit positioning as a life sciences hub, combined with government initiatives supporting biotech innovation, further strengthens market fundamentals.
- Investment in personalized medicine and complex disease modeling will accelerate adoption of specialized mouse strains and transgenic models.
- Collaboration between UK institutions and international pharmaceutical companies ensures continued market expansion and technological advancement in preclinical research methodologies..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The UK mice model market is valued at £86.2 million in 2025 and will reach £143.1 million by 2030, growing at 10.7% CAGR.
- The UK's leading pharmaceutical and biotechnology sector drives strong demand for preclinical research models.
- Advances in genetic engineering and personalized medicine are key growth drivers for the UK market through 2030.
- The UK's regulatory environment and research infrastructure support sustained market expansion and innovation.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
UK Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : UK and international pharma firms conducting preclinical research require detailed market data to optimize supplier selection, forecast procurement costs, and align R&D strategies with market availability.
- Biotech Research Organizations : UK-based biotech firms and academic research institutions need market insights to understand competitive dynamics, identify collaboration opportunities, and plan research infrastructure investments.
- Contract Research Organizations : CROs operating in the UK require market intelligence to benchmark service offerings, identify growth opportunities, and understand demand trends for specialized mice models and preclinical services.
- Investors and Venture Capitalists : Investment firms evaluating opportunities in UK life sciences need comprehensive market data to assess growth potential, competitive positioning, and return prospects in the mice model sector.
- Government and Policy Bodies : UK government agencies and policy makers benefit from market analysis to inform life sciences strategy, funding decisions, and regulatory frameworks supporting the nation's biotech ecosystem.
Key Companies in the UK Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- UK-Specific Market Intelligence : Gain detailed insights into the UK mice model market dynamics, including regional demand drivers, regulatory landscape, and competitive positioning specific to British pharmaceutical and biotech sectors.
- Investment Decision Support : Access comprehensive forecasts and growth projections through 2030 to inform capital allocation, market entry strategies, and expansion planning for UK-based or UK-focused life sciences organizations.
- Competitive Landscape Analysis : Understand the UK's leading academic institutions, CROs, and suppliers operating in the mice model space, enabling strategic partnerships and competitive benchmarking within the British market.
- Regulatory and Compliance Insights : Navigate UK-specific regulatory requirements, post-Brexit compliance frameworks, and quality standards that impact mice model procurement and utilization in preclinical research.
- Growth Opportunity Identification : Identify high-potential segments within the UK market, including emerging research areas, specialized mouse strains, and technological innovations driving the 10.7% CAGR growth trajectory.
Frequently asked questions
What is the current size of the UK mice model market?
The UK mice model market is valued at £86.2 million in 2025 and is projected to reach £143.1 million by 2030.
What is the growth rate of the UK mice model market?
The UK mice model market is expected to grow at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2030.
What drives demand for mice models in the UK?
The UK's robust pharmaceutical and biotechnology research sector, leading academic institutions, and contract research organizations drive significant demand for preclinical testing models.
How does the UK regulatory environment support the mice model market?
The UK's strong regulatory framework and commitment to advancing life sciences while refining animal testing methodologies create a supportive environment for market growth.
What are the key growth drivers for the UK market through 2030?
Key growth drivers include advances in genetic engineering, personalized medicine initiatives, increasing R&D investment, and the rising complexity of disease models required for modern drug discovery.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report